Substituted carbonucleoside derivatives useful as anticancer agents
US10709709B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2018 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | Dec 18, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C255/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the general formula): processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.